» Articles » PMID: 18557893

Regulation of SRF/CArG-dependent Gene Transcription During Chronic Partial Obstruction of Murine Small Intestine

Overview
Date 2008 Jun 19
PMID 18557893
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal obstructions lead to a variety of motility disorders. Small intestine smooth muscles undergo dramatic phenotypic changes in response to obstruction, but the underlying molecular mechanisms are unknown. Using RT-PCR, ChIP, Re-ChIP, and Western blots, we examined the effect of small bowel mechanical obstruction on smooth muscle gene expression. Obstruction caused a transient hyperplasia, followed by a prolonged hypertrophic response of small intestine smooth muscle cells. Smooth muscle myosin heavy chain (MHC), alpha-actin, and gamma-actin expression decreased initially, and then increased as hypertrophy developed. Myocardin expression decreased initially and then increased, while kruppel-like factors (KLF)4 and KLF5 expression increased initially, and then decreased. Serum response factor (SRF) expression decreased initially, and then recovered to sham-operated levels as hypertrophy developed. SRF binding to smooth muscle MHC and alpha-actin promoters decreased initially, but then increased above sham-operated levels as hypertrophy developed. Elk-1 binding to smooth muscle myosin heavy chain and alpha-actin promoters increased initially, and then decreased to sham-operated levels as hypertrophy developed. c-fos expression increased initially, which was associated with increased SRF/Elk-1 binding to the c-fos promoter. The Elk-1 phosphorylation inhibitor U-0126 inhibited the increase in c-fos expression. These findings indicate a dynamic response of small intestine smooth muscles to bowel obstruction involving switching between differentiated, proliferative, and hypertrophic phenotypes. These results suggest that changes in the expression and interactions between SRF, myocardin, Elk-1, and c-fos play key roles in the phenotypic switching of small intestine smooth muscles in response to mechanical obstruction.

Citing Articles

Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton.

Hashmi S, Ceron R, Heuckeroth R Am J Physiol Gastrointest Liver Physiol. 2021; 320(6):G919-G935.

PMID: 33729000 PMC: 8285581. DOI: 10.1152/ajpgi.00066.2021.


Gastroparesis is associated with decreased FOXF1 and FOXF2 in humans, and loss of FOXF1 and FOXF2 results in gastroparesis in mice.

Herring B, Hoggatt A, Gupta A, Wo J Neurogastroenterol Motil. 2018; 31(3):e13528.

PMID: 30565344 PMC: 6821388. DOI: 10.1111/nmo.13528.


A Mouse Model of Intestinal Partial Obstruction.

Ha S, Wei L, Jorgensen B, Lee M, Park P, Poudrier S J Vis Exp. 2018; (133).

PMID: 29553517 PMC: 5931449. DOI: 10.3791/57381.


Transcriptome of interstitial cells of Cajal reveals unique and selective gene signatures.

Lee M, Ha S, Park C, Park P, Fuchs R, Wei L PLoS One. 2017; 12(4):e0176031.

PMID: 28426719 PMC: 5398589. DOI: 10.1371/journal.pone.0176031.


Multi-phenotypic Role of Serum Response Factor in the Gastrointestinal System.

Ro S J Neurogastroenterol Motil. 2016; 22(2):193-200.

PMID: 26727951 PMC: 4819857. DOI: 10.5056/jnm15183.


References
1.
Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, Nishimura G . Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res. 2005; 97(11):1132-41. DOI: 10.1161/01.RES.0000190613.22565.13. View

2.
Teg Pipes G, Creemers E, Olson E . The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 2006; 20(12):1545-56. DOI: 10.1101/gad.1428006. View

3.
Hendrix J, Wamhoff B, McDonald O, Sinha S, Yoshida T, Owens G . 5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. J Clin Invest. 2005; 115(2):418-27. PMC: 546420. DOI: 10.1172/JCI22648. View

4.
Jones M, Wessinger S . Small intestinal motility. Curr Opin Gastroenterol. 2006; 22(2):111-6. DOI: 10.1097/01.mog.0000203867.33008.52. View

5.
Favata M, Horiuchi K, Manos E, Daulerio A, Stradley D, Feeser W . Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 1998; 273(29):18623-32. DOI: 10.1074/jbc.273.29.18623. View